\-\ Texto\\:\\ \ \(0\)\
\-\ assymetry\\ of\\ parotid\\ region\ \(0\)\
\-\ large\\,\\ well\\-defined\\ heterogeneous\\ soft\\ tissue\\ mass\\ within\\ the\\ left\\ parotid\\ gland\\,\\ inferior\\ to\\ the\\ mastoid\\ process\\ with\\ apparent\\ extension\\ into\\ the\\ mastoid\\ segment\\ of\\ the\\ facial\\ nerve\\ canal\\.\\ \\ \ \(0\)\
\-\ there\\ is\\ partial\\ cystic\\ degeneration\\ within\\ the\\ lesion\\.\\ \\ \\ \\ there\\ was\\ normal\\ signal\\ in\\ the\\ labyrinthine\\,\\ tympanic\\ and\\ intracanalicular\\ segments\\ of\\ the\\ facial\\ nerve\\.\ \(0\)\
\-\ facial\\ nerve\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ facial\\ nerve\\ schwannoma\ \(0\)\
\-\ \\â\\€\\¢\\ perineural\\ spread\\:\\ lymphoma\\,\\ adenoid\\ cystic\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ pleomorphic\\ adenoma\\ \\(high\\ t2\\ signal\\)\ \(0\)\
\-\ \\â\\€\\¢\\ benign\\ lymphoepithelial\\ cysts\\:\\ mixed\\ solid\\ and\\ cystic\\ intraparotid\\ lesions\\ \\(high\\ t2\\ signal\\,\\ hiv\\ patients\\)\ \(0\)\
\-\ \\â\\€\\¢\\ other\\ parotid\\ masses\\:\\ benign\\ mixed\\ tumor\\,\\ warthin\\ tumor\\,\\ non\\ hodgkin\\ lymphona\\,\\ parotid\\ metastasis\\,\\ mucoepidermoid\\ carcinoma\ \(0\)\
\-\ 23\\ y\\.o\\.\\ woman\\ with\\ gradually\\ enlarging\\ left\\ parotid\\ mass\\.\\ \\ the\\ patient\\ complained\\ of\\ sharp\\ pain\\ in\\ her\\ left\\ face\\ along\\ with\\ twitching\\ of\\ her\\ left\\ eye\\,\\ and\\ difficulty\\ hearing\\ out\\ of\\ left\\ ear\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parotid\\:\\ 0\\.5012388236200245\ \(0\)\
\-\ facial\\:\\ 0\\.2785545736032822\ \(0\)\
\-\ nerve\\:\\ 0\\.24099597329198696\ \(0\)\
\-\ mastoid\\:\\ 0\\.17422222708005025\ \(0\)\
\-\ cystic\\:\\ 0\\.15259117918244777\ \(0\)\
\-\ schwannoma\\:\\ 0\\.14474731663853932\ \(0\)\
\-\ left\\:\\ 0\\.14404538009477755\ \(0\)\
\-\ signal\\:\\ 0\\.14362358815900497\ \(0\)\
\-\ mixed\\:\\ 0\\.13981730700539685\ \(0\)\
\-\ intraparotid\\:\\ 0\\.13506021297171567\ \(0\)\
\-\ the\\:\\ 0\\.13481294680181516\ \(0\)\
\-\ labyrinthine\\:\\ 0\\.12905724383726308\ \(0\)\
\-\ lymphoepithelial\\:\\ 0\\.12905724383726308\ \(0\)\
\-\ lymphona\\:\\ 0\\.12905724383726308\ \(0\)\
\-\ assymetry\\:\\ 0\\.11879510032028207\ \(0\)\
\-\ warthin\\:\\ 0\\.11651287737543853\ \(0\)\
\-\ mucoepidermoid\\:\\ 0\\.11651287737543853\ \(0\)\
\-\ benign\\:\\ 0\\.11602829375595172\ \(0\)\
\-\ twitching\\:\\ 0\\.11453592593775366\ \(0\)\
\-\ perineural\\:\\ 0\\.11279213118582944\ \(0\)\
\-\ intracanalicular\\:\\ 0\\.11123225362587127\ \(0\)\
\-\ her\\:\\ 0\\.1055240439397137\ \(0\)\
\-\ adenoid\\:\\ 0\\.10337622619145875\ \(0\)\
\-\ carcinoma\\:\\ 0\\.10103304237157042\ \(0\)\
\-\ of\\:\\ 0\\.09916355676829472\ \(0\)\
\-\ t2\\:\\ 0\\.09717734949376795\ \(0\)\
\-\ high\\:\\ 0\\.09599615578760418\ \(0\)\
\-\ tympanic\\:\\ 0\\.0959885903414765\ \(0\)\
\-\ tumor\\:\\ 0\\.08834860629901217\ \(0\)\
\-\ gradually\\:\\ 0\\.08800866976933903\ \(0\)\
\-\ hodgkin\\:\\ 0\\.08626487501741482\ \(0\)\
\-\ segments\\:\\ 0\\.0857264468244955\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.08546440204457273\ \(0\)\
\-\ hiv\\:\\ 0\\.08351995367935164\ \(0\)\
\-\ sharp\\:\\ 0\\.08307127862941188\ \(0\)\
\-\ complained\\:\\ 0\\.08140132514557424\ \(0\)\
\-\ enlarging\\:\\ 0\\.07886745064240767\ \(0\)\
\-\ degeneration\\:\\ 0\\.07853843391193788\ \(0\)\
\-\ within\\:\\ 0\\.07779374790058682\ \(0\)\
\-\ ear\\:\\ 0\\.07684897002304411\ \(0\)\
\-\ hearing\\:\\ 0\\.07670452845237333\ \(0\)\
\-\ face\\:\\ 0\\.07614045475925865\ \(0\)\
\-\ spread\\:\\ 0\\.07586627759845466\ \(0\)\
\-\ difficulty\\:\\ 0\\.07104080821974723\ \(0\)\
\-\ apparent\\:\\ 0\\.07065372359436438\ \(0\)\
\-\ segment\\:\\ 0\\.06972810073378082\ \(0\)\
\-\ 23\\:\\ 0\\.06963864340082054\ \(0\)\
\-\ gland\\:\\ 0\\.06860530712542667\ \(0\)\
\-\ eye\\:\\ 0\\.06756169436568461\ \(0\)\
\-\ adenoma\\:\\ 0\\.06733096018562534\ \(0\)\
\-\ there\\:\\ 0\\.06720790992339877\ \(0\)\
\-\ partial\\:\\ 0\\.0650705576479164\ \(0\)\
\-\ canal\\:\\ 0\\.0650051926695067\ \(0\)\
\-\ solid\\:\\ 0\\.06474658096636704\ \(0\)\
\-\ mass\\:\\ 0\\.06451829025108395\ \(0\)\
\-\ cysts\\:\\ 0\\.0639967932315286\ \(0\)\
\-\ process\\:\\ 0\\.06334132772113224\ \(0\)\
\-\ metastasis\\:\\ 0\\.06189848747865108\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.06112586991113027\ \(0\)\
\-\ extension\\:\\ 0\\.0597833843987684\ \(0\)\
\-\ masses\\:\\ 0\\.05749461485043069\ \(0\)\
\-\ inferior\\:\\ 0\\.05745539590415665\ \(0\)\
\-\ along\\:\\ 0\\.05658089705928954\ \(0\)\
\-\ out\\:\\ 0\\.05551275535914184\ \(0\)\
\-\ and\\:\\ 0\\.0523541093812649\ \(0\)\
\-\ region\\:\\ 0\\.05051652118578521\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05029754218630377\ \(0\)\
\-\ with\\:\\ 0\\.0496114034849172\ \(0\)\
\-\ lesions\\:\\ 0\\.048502847587328445\ \(0\)\
\-\ patients\\:\\ 0\\.04750995202578624\ \(0\)\
\-\ soft\\:\\ 0\\.04496147291041811\ \(0\)\
\-\ into\\:\\ 0\\.044894253073895836\ \(0\)\
\-\ tissue\\:\\ 0\\.04430262589053805\ \(0\)\
\-\ woman\\:\\ 0\\.04398388067156313\ \(0\)\
\-\ other\\:\\ 0\\.04385827954870683\ \(0\)\
\-\ large\\:\\ 0\\.042315609088701245\ \(0\)\
\-\ in\\:\\ 0\\.04201879170599106\ \(0\)\
\-\ lesion\\:\\ 0\\.04048909074285125\ \(0\)\
\-\ non\\:\\ 0\\.04007167098692107\ \(0\)\
\-\ normal\\:\\ 0\\.03448197160316871\ \(0\)\
\-\ pain\\:\\ 0\\.030220722654174244\ \(0\)\
\-\ was\\:\\ 0\\.029433029262238578\ \(0\)\
\-\ patient\\:\\ 0\\.027468622368406595\ \(0\)\
\-\ is\\:\\ 0\\.023128281351366842\ \(0\)\
\-\ to\\:\\ 0\\.02111331554839756\ \(0\)\
